News & Publications

OCG is committed to sharing its research with the community. Stay informed by reading the latest news & publications and subscribing to the OCG e-Newsletter.

Publications

Graphical abstract from Yong, et al (2019).
CTD²
Cancer Cell

We demonstrate that concurrent administration of poly(ADP-ribose) polymerase (PARP) and WEE1 inhibitors is effective in inhibiting tumor growth but poorly tolerated. Concurrent treatment with PARP and WEE1 inhibitorsinduces replication stress, DNA damage, and abrogates the G2 DNA damage...

Integrative genomic analysis to identify mediators of BETi response
CTD²
Nature Communications

BET-bromodomain inhibition (BETi) has shown pre-clinical promise for MYC-amplified medulloblastoma. However, the mechanisms for its action, and ultimately for resistance, have not been fully defined. Here, using a combination of expression profiling, genome-scale CRISPR/Cas9-mediated loss of...

Last updated: June 21, 2019